High-throughput analysis of the transcriptional patterns of sexual genes in malaria.

Automatization Gametocyte Gametocytogenesis Gene expression Malaria Plasmodium falciparum RT-qPCR

Journal

Parasites & vectors
ISSN: 1756-3305
Titre abrégé: Parasit Vectors
Pays: England
ID NLM: 101462774

Informations de publication

Date de publication:
13 Jan 2023
Historique:
received: 09 05 2022
accepted: 17 12 2022
entrez: 13 1 2023
pubmed: 14 1 2023
medline: 18 1 2023
Statut: epublish

Résumé

Plasmodium falciparum (Pf) is the leading protozoan causing malaria, the most devastating parasitic disease. To ensure transmission, a small subset of Pf parasites differentiate into the sexual forms (gametocytes). Since the abundance of these essential parasitic forms is extremely low within the human host, little is currently known about the molecular regulation of their sexual differentiation, highlighting the need to develop tools to investigate Pf gene expression during this fundamental mechanism. We developed a high-throughput quantitative Reverse-Transcription PCR (RT-qPCR) platform to robustly monitor Pf transcriptional patterns, in particular, systematically profiling the transcriptional pattern of a large panel of gametocyte-related genes (GRG). Initially, we evaluated the technical performance of the systematic RT-qPCR platform to ensure it complies with the accepted quality standards for: (i) RNA extraction, (ii) cDNA synthesis and (iii) evaluation of gene expression through RT-qPCR. We then used this approach to monitor alterations in gene expression of a panel of GRG upon treatment with gametocytogenesis regulators. We thoroughly elucidated GRG expression profiles under treatment with the antimalarial drug dihydroartemisinin (DHA) or the metabolite choline over the course of a Pf blood cycle (48 h). We demonstrate that both significantly alter the expression pattern of PfAP2-G, the gametocytogenesis master regulator. However, they also markedly modify the developmental rate of the parasites and thus might bias the mRNA expression. Additionally, we screened the effect of the metabolites lactate and kynurenic acid, abundant in severe malaria, as potential regulators of gametocytogenesis. Our data demonstrate that the high-throughput RT-qPCR method enables studying the immediate transcriptional response initiating gametocytogenesis of the parasites from a very low volume of malaria-infected RBC samples. The obtained data expand the current knowledge of the initial alterations in mRNA profiles of GRG upon treatment with reported regulators. In addition, using this method emphasizes that asexual parasite stage composition is a crucial element that must be considered when interpreting changes in GRG expression by RT-qPCR, specifically when screening for novel compounds that could regulate Pf sexual differentiation.

Sections du résumé

BACKGROUND BACKGROUND
Plasmodium falciparum (Pf) is the leading protozoan causing malaria, the most devastating parasitic disease. To ensure transmission, a small subset of Pf parasites differentiate into the sexual forms (gametocytes). Since the abundance of these essential parasitic forms is extremely low within the human host, little is currently known about the molecular regulation of their sexual differentiation, highlighting the need to develop tools to investigate Pf gene expression during this fundamental mechanism.
METHODS METHODS
We developed a high-throughput quantitative Reverse-Transcription PCR (RT-qPCR) platform to robustly monitor Pf transcriptional patterns, in particular, systematically profiling the transcriptional pattern of a large panel of gametocyte-related genes (GRG). Initially, we evaluated the technical performance of the systematic RT-qPCR platform to ensure it complies with the accepted quality standards for: (i) RNA extraction, (ii) cDNA synthesis and (iii) evaluation of gene expression through RT-qPCR. We then used this approach to monitor alterations in gene expression of a panel of GRG upon treatment with gametocytogenesis regulators.
RESULTS RESULTS
We thoroughly elucidated GRG expression profiles under treatment with the antimalarial drug dihydroartemisinin (DHA) or the metabolite choline over the course of a Pf blood cycle (48 h). We demonstrate that both significantly alter the expression pattern of PfAP2-G, the gametocytogenesis master regulator. However, they also markedly modify the developmental rate of the parasites and thus might bias the mRNA expression. Additionally, we screened the effect of the metabolites lactate and kynurenic acid, abundant in severe malaria, as potential regulators of gametocytogenesis.
CONCLUSIONS CONCLUSIONS
Our data demonstrate that the high-throughput RT-qPCR method enables studying the immediate transcriptional response initiating gametocytogenesis of the parasites from a very low volume of malaria-infected RBC samples. The obtained data expand the current knowledge of the initial alterations in mRNA profiles of GRG upon treatment with reported regulators. In addition, using this method emphasizes that asexual parasite stage composition is a crucial element that must be considered when interpreting changes in GRG expression by RT-qPCR, specifically when screening for novel compounds that could regulate Pf sexual differentiation.

Identifiants

pubmed: 36639683
doi: 10.1186/s13071-022-05624-w
pii: 10.1186/s13071-022-05624-w
pmc: PMC9838061
doi:

Substances chimiques

Antimalarials 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

14

Subventions

Organisme : Horizon 2020
ID : 757743
Organisme : Horizon 2020
ID : 757743
Organisme : Horizon 2020
ID : 757743
Organisme : Horizon 2020
ID : 757743
Organisme : Horizon 2020
ID : 757743
Organisme : Israel Science Foundation
ID : 570/21
Organisme : Israel Science Foundation
ID : 570/21
Organisme : Israel Science Foundation
ID : 570/21
Organisme : Israel Science Foundation
ID : 570/21
Organisme : Israel Science Foundation
ID : 570/21

Informations de copyright

© 2023. The Author(s).

Références

Mol Biochem Parasitol. 2009 Feb;163(2):123-6
pubmed: 19027798
Methods Mol Med. 2002;72:151-7
pubmed: 12125112
J Biol Chem. 1998 May 15;273(20):12003-5
pubmed: 9575140
Cell Microbiol. 2016 Jul;18(7):905-18
pubmed: 27111866
Cell Host Microbe. 2012 Jan 19;11(1):1-2
pubmed: 22264506
Mol Biochem Parasitol. 1999 Mar 15;99(1):143-8
pubmed: 10215031
PLoS Pathog. 2021 Jan 7;17(1):e1009122
pubmed: 33411818
Sci Rep. 2017 Jan 16;7:40213
pubmed: 28091526
Nat Rev Dis Primers. 2017 Aug 03;3:17050
pubmed: 28770814
Nat Commun. 2020 Mar 20;11(1):1503
pubmed: 32198457
PLoS Pathog. 2012;8(10):e1002964
pubmed: 23093935
Mol Biochem Parasitol. 1994 May;65(1):11-22
pubmed: 7935618
Nat Commun. 2022 May 30;13(1):3004
pubmed: 35637187
Nature. 2014 Mar 13;507(7491):253-257
pubmed: 24572359
Clin Chem. 2009 Apr;55(4):611-22
pubmed: 19246619
Nucleic Acids Res. 2017 Feb 28;45(4):1889-1901
pubmed: 27994033
J Biol Chem. 2008 Oct 10;283(41):27636-27643
pubmed: 18694927
J Pak Med Assoc. 2016 Dec;66(12):1587-1591
pubmed: 28179695
Anal Biochem. 2006 Apr 15;351(2):308-10
pubmed: 16524557
J Biol Chem. 2018 Nov 9;293(45):17308-17316
pubmed: 30287688
Malar J. 2015 Aug 28;14:334
pubmed: 26315106
Nature. 2017 Nov 2;551(7678):95-99
pubmed: 29094698
Mol Biochem Parasitol. 1993 Feb;57(2):269-79
pubmed: 8433718
Biotechniques. 1995 Jan;18(1):62-3
pubmed: 7702855
Cell Host Microbe. 2014 Aug 13;16(2):165-176
pubmed: 25121746
Cell. 2017 Dec 14;171(7):1532-1544.e15
pubmed: 29129376
Annu Rev Microbiol. 2018 Sep 08;72:501-519
pubmed: 29975590
Sci Rep. 2019 Oct 10;9(1):14595
pubmed: 31601834
Mol Microbiol. 2010 Apr;76(1):12-24
pubmed: 20141604
Nature. 2014 Mar 13;507(7491):248-52
pubmed: 24572369
Nat Commun. 2019 May 13;10(1):2140
pubmed: 31086187
PLoS One. 2015 Mar 25;10(3):e0121057
pubmed: 25807235
Mol Biochem Parasitol. 2007 Jul;154(1):119-23
pubmed: 17521751
Cell Host Microbe. 2018 Mar 14;23(3):407-420.e8
pubmed: 29503181
BMC Genomics. 2019 Dec 3;20(1):920
pubmed: 31795940
Malar J. 2017 Jul 28;16(1):303
pubmed: 28754152
Am J Trop Med Hyg. 2017 Jul;97(1):188-198
pubmed: 28719294
Cell Microbiol. 2020 Mar;22(3):e13146
pubmed: 31734953
J Bacteriol. 1984 Dec;160(3):1165-7
pubmed: 6389509
Nat Rev Microbiol. 2015 Sep;13(9):573-87
pubmed: 26272409
J Infect Dis. 2003 Sep 15;188(6):844-9
pubmed: 12964115
Parasitology. 2004 Sep;129(Pt 3):255-62
pubmed: 15471001
BMC Genomics. 2008 Oct 30;9:513
pubmed: 18973684
Parasitology. 2018 Nov;145(13):1772-1782
pubmed: 30008275
Malar J. 2004 Jul 14;3:24
pubmed: 15253774
Parasitology. 1999 Apr;118 ( Pt 4):339-46
pubmed: 10340323
J Parasitol. 1979 Jun;65(3):418-20
pubmed: 383936
Nat Protoc. 2016 Sep;11(9):1668-80
pubmed: 27560172
Elife. 2020 Oct 21;9:
pubmed: 33084568
J Protozool. 1992 May-Jun;39(3):429-32
pubmed: 1640389
Nature. 2007 Dec 13;450(7172):1091-5
pubmed: 18046333
Front Cell Infect Microbiol. 2022 Feb 11;12:802341
pubmed: 35223540
Mol Cell Proteomics. 2010 Jul;9(7):1437-48
pubmed: 20332084
Science. 2018 Mar 16;359(6381):1259-1263
pubmed: 29590075
J Infect Dis. 2009 Nov 15;200(10):1518-21
pubmed: 19848586
Nat Commun. 2017 Dec 7;8(1):1985
pubmed: 29215015
Infect Immun. 2020 Dec 15;89(1):
pubmed: 33077626
J Infect Dis. 2011 May 15;203(10):1445-53
pubmed: 21502082
Sci Adv. 2020 Jun 10;6(24):eaaz5057
pubmed: 32577509
BMC Med. 2016 May 24;14:79
pubmed: 27221542
J Parasitol Res. 2012;2012:927148
pubmed: 22523643
Antimicrob Agents Chemother. 2013 Mar;57(3):1455-67
pubmed: 23318799
Cell Host Microbe. 2014 Aug 13;16(2):177-186
pubmed: 25121747
Exp Parasitol. 1989 Aug;69(2):140-9
pubmed: 2666152
PLoS Biol. 2003 Oct;1(1):E5
pubmed: 12929205
Future Microbiol. 2011 Nov;6(11):1351-69
pubmed: 22082293
J Travel Med. 2005 Sep-Oct;12(5):261-4
pubmed: 16256049
Cold Spring Harb Protoc. 2010 Jun;2010(6):pdb.prot5445
pubmed: 20516183
Nat Microbiol. 2022 Feb;7(2):289-299
pubmed: 35087229
Malar J. 2020 Oct 9;19(1):363
pubmed: 33036628
Methods. 2017 Jan 1;112:157-166
pubmed: 27350362
Mol Biochem Parasitol. 2005 Sep;143(1):90-9
pubmed: 15996767
Nat Microbiol. 2019 Jan;4(1):144-154
pubmed: 30478286
Cell Host Microbe. 2009 Feb 19;5(2):179-90
pubmed: 19218088
Malar J. 2019 Apr 30;18(1):154
pubmed: 31039781
Science. 1976 Aug 20;193(4254):673-5
pubmed: 781840
Nat Commun. 2020 Dec 2;11(1):6159
pubmed: 33268801
PLoS Pathog. 2009 Sep;5(9):e1000569
pubmed: 19730695
Methods Mol Biol. 2021;2369:165-185
pubmed: 34313989
Nat Protoc. 2015 Aug;10(8):1131-42
pubmed: 26134953
BMC Mol Biol. 2006 Jan 31;7:3
pubmed: 16448564
Anal Biochem. 1987 Apr;162(1):156-9
pubmed: 2440339

Auteurs

Abel Cruz Camacho (A)

Faculty of Biochemistry, Department of Biomolecular Sciences, Weizmann Institute of Science, 7610001, Rehovot, Israel.

Edo Kiper (E)

Faculty of Biochemistry, Department of Biomolecular Sciences, Weizmann Institute of Science, 7610001, Rehovot, Israel.

Sonia Oren (S)

Faculty of Biochemistry, Department of Biomolecular Sciences, Weizmann Institute of Science, 7610001, Rehovot, Israel.

Nir Zaharoni (N)

Faculty of Biochemistry, Department of Biomolecular Sciences, Weizmann Institute of Science, 7610001, Rehovot, Israel.

Netta Nir (N)

Faculty of Biochemistry, Department of Biomolecular Sciences, Weizmann Institute of Science, 7610001, Rehovot, Israel.

Noam Soffer (N)

Faculty of Biochemistry, Department of Biomolecular Sciences, Weizmann Institute of Science, 7610001, Rehovot, Israel.

Yael Noy (Y)

Faculty of Biochemistry, Department of Biomolecular Sciences, Weizmann Institute of Science, 7610001, Rehovot, Israel.

Bar Ben David (B)

Faculty of Biochemistry, Department of Biomolecular Sciences, Weizmann Institute of Science, 7610001, Rehovot, Israel.

Anna Rivkin (A)

Faculty of Biochemistry, Department of Biomolecular Sciences, Weizmann Institute of Science, 7610001, Rehovot, Israel.

Ron Rotkopf (R)

Department of Life Sciences Core Facilities, Weizmann Institute of Science, 7610001, Rehovot, Israel.

Dan Michael (D)

Feinberg Graduate School, Weizmann Institute of Science, 7610001, Rehovot, Israel.

Teresa G Carvalho (TG)

Department of Microbiology, Anatomy, Physiology and Pharmacology, La Trobe University, Melbourne, VIC, 3086, Australia.

Neta Regev-Rudzki (N)

Faculty of Biochemistry, Department of Biomolecular Sciences, Weizmann Institute of Science, 7610001, Rehovot, Israel. neta.regev-rudzki@weizmann.ac.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH